Biora Therapeutics
Stock Forecast, Prediction & Price Target
Biora Therapeutics Financial Estimates
Biora Therapeutics Revenue Estimates
Biora Therapeutics EBITDA Estimates
Biora Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.24M N/A | $305K -75.54% | $4K -98.68% | Avg: $2.50M Low: $2.49M High: $2.50M avg. 62462.5% | Avg: $2.76M Low: $2.75M High: $2.76M avg. 10.38% | Avg: $6.1M Low: $6.08M High: $6.11M avg. 120.81% | Avg: $20.6M Low: $20.56M High: $20.63M avg. 237.70% |
Net Income
% change YoY
| $-178.52M N/A | $-48.83M 72.64% | $-124.11M -154.17% | Avg: $-75.53M Low: $-24.44M High: $-14.66M avg. 39.13% | Avg: $-81.07M Low: $-21.13M High: $-14.98M avg. -7.32% | Avg: $-20.50M Low: $-20.55M High: $-20.45M avg. 74.70% | Avg: $-17.82M Low: $-17.86M High: $-17.78M avg. 13.07% |
EBITDA
% change YoY
| $-63.68M N/A | $-59.16M 7.09% | $-114.05M -92.77% | Avg: $-2.46M Low: $-2.46M High: $-2.46M avg. 97.83% | Avg: $-2.72M Low: $-2.72M High: $-2.71M avg. -10.38% | Avg: $-6.00M Low: $-6.01M High: $-5.99M avg. -120.81% | Avg: $-20.29M Low: $-20.32M High: $-20.25M avg. -237.70% |
EPS
% change YoY
| -$46.42 N/A | -$6.4 86.21% | -$7.87 -22.96% | Avg: -$1.24 Low: -$1.55 High: -$0.93 avg. 84.24% | Avg: -$1.15 Low: -$1.34 High: -$0.95 avg. 7.66% | Avg: -$1.3 Low: -$1.3 High: -$1.3 avg. -13.53% | Avg: -$1.13 Low: -$1.13 High: -$1.13 avg. 13.07% |
Operating Expenses
% change YoY
| $119.08M N/A | $62.08M -47.86% | $67.14M 8.15% | Avg: $4.69B Low: $4.68B High: $4.70B avg. 6887.60% | Avg: $5.17B Low: $5.17B High: $5.18B avg. 10.38% | Avg: $11.43B Low: $11.41B High: $11.45B avg. 120.81% | Avg: $38.62B Low: $38.55B High: $38.69B avg. 237.70% |
FAQ
What is Biora Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 29.89% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -24.44M, average is -75.53M and high is -14.66M.
What is Biora Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 15707.85% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $2.49M, average is $2.50M and high is $2.50M.
What is Biora Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 22.86% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.55, average is -$1.24 and high is $-0.93.